Search PubMed⌕ Search

Biomedical subjects

D J Nazir

Publications and source records attributed to D J Nazir.

32 records · Page 2Linked to original sources

Effect of dietary di-2-ethylhexyl phthalate on lipid biosynthesis in selected tissues from the rat, in vitro.

Di-2-ethylhexyl phthalate (DEHP), a plasticizer commonly used in the production of polyvinyl chloride plastics, has become an environmental pollutant. At the present time, the biological significance of phthalates in the environment is unknown. In the present studies, we observed that addition of DEHP to a stock diet of rats resulted in marked effects on incorporation of 14C-acetate into lipid by liver and kidney slices; other organs, such as heart, testes, and aorta, were unaffected. Incorporation of 14C-acetate into total lipid of liver (dpm/mg wet wt) from rats fed 0.5% or 1.0% DEHP for 10 or 18 days, respectively, was decreased to ca. 50% of control values. The decreased incorporation into liver lipid is not attributable to any one lipid fraction, inasmuch as incorporation into the phospholipid, sterol + diglyceride, free fatty acid, triglyceride, and sterol ester + hydrocarbon fractions was decreased 30-70% with respect to controls. In addition, the percent distribution of 14C-acetate among the individual phospholipids was ca. 25% lower in phosphatidyl choline of the DEHP-fed rats. In rats fed 0.5% DEHP, incorporation of 14C-acetate into total lipid of kidney was similar to control values, but incorporation into the triglyceride and sterol ester + hydrocarbon fraction was decreased 30-40%, whereas incorporation into the sterol + diglyceride fraction was increased 38%. Livers from DEHP-fed rats were ca. 20% larger than livers from control rats and, at the 0.5% level of DEHP feeding, testes wts were elevated; no significant changes were noted in wts of spleen, heart, aorta, kidney, or body wt gains in rats fed DEHP. These studies emphasize a subtle toxicity of phthalate esters not previously reported and emphasize the need for further biochemical studies to evaluate the effect of phthalates on biological systems.

Animals↗

Fatty acid composition of margarines.

The fatty acid composition of 27 samples of bar margarines, 58 samples of tub margarines, and one sample of a liquid margarine spread, purchased at different centers in Canada and the United States over a 1-year period (1973-1974), has been determined. The values of total polyunsaturated fatty acids determined by gas-liquid chromatography were compared to the results obtained by an enzymatic method using lipoxidase. The margarines have also been compared on the basis of fatty acid composition and polyunsaturated to saturated fatty acid ratios. All of these parameters showed considerable variations among the different samples analyzed in this study. As a general rule, soft (tub) margarines tended to have a higher concentration of cis,cis-9,12-octadecadienoic (linoleic) acid than hard (bar) margarines. The labeling of the products as regards fatty acid composition was not always helpful in choosing a margarine of high linoleic acid composition.

Canada↗

The effect of calcium on plasma lipids and bile acid and fecal fat excretion in normolipidemic subjects.

The effect of oral calcium (2 g/day) was studied in four normolipidemic subjects. Calcium caused a significant lowering of plasma cholesterol and a considerable fall in the glycine-/taurine-conjugated bile acid ratio in the intestinal aspirate of one subject, while fecal bile acid excretion rose appreciably in another during treatment. These parameters showed no consistent trend in the other three subjects. None of the subjects showed any significant change in plasma triglycerides and serum calcium and phosphorus during treatment. One subject showed a consistent decrease in every parameter studied throughout the experiment, a trend which was probably due to a concomitant loss in body weight.

Adult↗

A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinaemia.

Type III hyperlipoproteinaemia (HLP) has been overdiagnosed in the past, but still may go undiagnosed because of technical difficulties. This longitudinal study of 19 ultracentrifugally proven cases of Type III HLP shows that 2 lipid ratios can be used to supplement the findings of a floating beta band. These patients have been followed for 3 months to 2.5 years whilst on dietary and/or drug treatment. A group composed of more than 100 Type IIB, Type IV and Type IIB-IV hyperlipoproteinaemic patients has been used for comparison purposes. From a total of 310 ultracentrifugal analyses, it was found that the following 2 ratios have more than a 90 percent predictability for Type III HLP: supernatant cholesterol/supernatant triglyceride greater than or equal to 0.35 (Ratio 2); supernatant cholesterol/whole plasma triglyceride greater than or equal to 0.25 (Ratio 3). These ratios are particularly valuable in Type III HLP when the plasma is grossly hyperlipaemic or when the lipid levels are low because of successful treatment.

Adolescent↗

Effect of cholestyramine on tissue pools of cholesterol a preliminary report.

Four Type II Hyperlipoproteinemic subjects were investigated before and after treatment with cholestyramine. Plasma cholesterol was significantly reduced (365 plus or minus 23 vs 273 plus or minus 34 mg/100 ml) and triglycerides significantly increased (149 plus or minus 55 vs 181 plus or minus 59 mg/100 ml) on cholestyramine treatment. The daily turnover of cholesterol, as determined by the method of Goodman and Nobel, was nearly doubled by the treatment (0.813 plus or minus 0.11 vs 1.595 plus or minus 0.176 g). Although previous workers have already suggested that cholestyramine does not decrease tissue cholesterol pools, we observed a significant increase in tissue pools in each of the three subjects given cholestyramine alone (10.1 plus or minus 1.4 vs 16.2 plus or minus 6.9 g) for Pool A - EXCLUDING PLASMA; AND 27.2 PLUS OR MINUS 4.6 VS 43.7 PLUS OR MINUS 6.4 G FOR Pool B). Treatment for the fourth subject consisted of a combination of cholestyramine and clofibrate. This combination appeared to prevent increases in the size of Pool B and in the size and production rate of Pool A. These preliminary observations suggest that the hypocholesterolemic effect of cholestyramine may be enhanced and its effects on tissue cholesterol prevented by giving it in combination with other agents such as clofibrate.

Adult↗